Charlemagne Capital
Latest statistics and disclosures from Charlemagne Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ITUB, BABA, BBD, Petrobras Energia Participaciones SA, BIDU, and represent 43.92% of Charlemagne Capital's stock portfolio.
- Added to shares of these 10 stocks: BRFS (+$10M), YPF (+$9.3M), Petrobras Energia Participaciones SA (+$7.8M), PAM, BABA, BMA, EPAM, SUPV, VIPS, TEO.
- Started 2 new stock positions in YPF, Synergy Pharmaceuticals.
- Reduced shares in these 10 stocks: , ABEV, ITUB, MELI, TAL, Luxoft Holding Inc cmn, GGAL, Nord Anglia Education, TGS, BIDU.
- Sold out of its positions in GGAL, Vimpel, Nord Anglia Education.
- Charlemagne Capital was a net buyer of stock by $7.9M.
- Charlemagne Capital has $213M in assets under management (AUM), dropping by 23.29%.
- Central Index Key (CIK): 0001351841
Portfolio Holdings for Charlemagne Capital
Charlemagne Capital holds 39 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Banco Itau Holding Financeira (ITUB) | 14.5 | $31M | -6% | 2.6M | 12.08 |
|
| Alibaba Group Holding (BABA) | 10.1 | $21M | +11% | 198k | 108.09 |
|
| Banco Bradesco SA (BBD) | 7.6 | $16M | 1.6M | 10.30 |
|
|
| Petrobras Energia Participaciones SA | 6.0 | $13M | +156% | 1.2M | 11.06 |
|
| Baidu (BIDU) | 5.8 | $12M | -4% | 71k | 173.01 |
|
| Edenor (EDN) | 5.1 | $11M | +11% | 312k | 34.65 |
|
| BRF Brasil Foods SA (BRFS) | 4.8 | $10M | +6901% | 829k | 12.27 |
|
| Pampa Energia (PAM) | 4.4 | $9.3M | +49% | 171k | 54.42 |
|
| Ypf Sa (YPF) | 4.4 | $9.3M | NEW | 383k | 24.21 |
|
| Depository Vipshop Holdings Ltd - Ads receipt (VIPS) | 4.0 | $8.4M | +18% | 631k | 13.34 |
|
| Transportadora de Gas del Sur SA (TGS) | 3.7 | $7.9M | -7% | 555k | 14.24 |
|
| Luxoft Holding Inc cmn | 3.6 | $7.7M | -11% | 122k | 62.60 |
|
| Fomento Economico Mexicano SAB (FMX) | 3.5 | $7.5M | -5% | 85k | 88.62 |
|
| Credicorp (BAP) | 3.4 | $7.1M | -6% | 44k | 163.55 |
|
| Ambev Sa- (ABEV) | 3.2 | $6.8M | -31% | 1.2M | 5.77 |
|
| Banco Macro SA (BMA) | 2.8 | $5.9M | +52% | 68k | 86.55 |
|
| Petroleo Brasileiro SA (PBR.A) | 2.5 | $5.3M | -8% | 571k | 9.25 |
|
| Telecom Argentina (TEO) | 2.2 | $4.8M | +33% | 215k | 22.11 |
|
| TAL Education (TAL) | 2.2 | $4.7M | -24% | 44k | 106.48 |
|
| Grupo Supervielle S A (SUPV) | 2.0 | $4.2M | +49% | 246k | 16.98 |
|
| Epam Systems (EPAM) | 1.4 | $3.0M | +154% | 39k | 75.70 |
|
| MercadoLibre (MELI) | 1.1 | $2.3M | -41% | 11k | 211.94 |
|
| Gilead Sciences (GILD) | 0.2 | $441k | 6.5k | 68.14 |
|
|
| Penumbra (PEN) | 0.2 | $355k | 4.2k | 83.92 |
|
|
| Merck & Co (MRK) | 0.2 | $344k | 5.4k | 63.56 |
|
|
| Vale (VALE) | 0.1 | $288k | +44% | 30k | 9.57 |
|
| Pfizer (PFE) | 0.1 | $290k | 8.5k | 34.25 |
|
|
| Amgen (AMGN) | 0.1 | $268k | 1.6k | 164.12 |
|
|
| Eli Lilly & Co. (LLY) | 0.1 | $264k | 3.1k | 84.21 |
|
|
| Ultrapar Participacoes SA (UGP) | 0.1 | $261k | -4% | 12k | 22.78 |
|
| Celgene Corporation | 0.1 | $252k | 2.0k | 124.38 |
|
|
| Bristol Myers Squibb (BMY) | 0.1 | $237k | 4.3k | 54.52 |
|
|
| Neurocrine Biosciences (NBIX) | 0.1 | $242k | 5.6k | 43.34 |
|
|
| Akorn | 0.1 | $187k | 7.8k | 24.09 |
|
|
| Synergy Pharmaceuticals | 0.1 | $190k | NEW | 41k | 4.68 |
|
| Arrowhead Pharmaceuticals (ARWR) | 0.1 | $193k | 103k | 1.88 |
|
|
| Lannett Company | 0.1 | $142k | 6.3k | 22.46 |
|
|
| Amarin Corporation (AMRN) | 0.1 | $121k | 38k | 3.19 |
|
|
| Telefonica Brasil Sa | 0.1 | $106k | -8% | 7.1k | 14.84 |
|
Past Filings by Charlemagne Capital
SEC 13F filings are viewable for Charlemagne Capital going back to 2011
- Charlemagne Capital 2017 Q1 filed May 15, 2017
- Charlemagne Capital 2016 Q4 filed Feb. 13, 2017
- Charlemagne Capital 2016 Q3 filed Nov. 10, 2016
- Charlemagne Capital 2016 Q2 filed Aug. 11, 2016
- Charlemagne Capital 2016 Q1 filed May 5, 2016
- Charlemagne Capital 2015 Q4 filed Feb. 16, 2016
- Charlemagne Capital 2015 Q3 filed Nov. 9, 2015
- Charlemagne Capital 2015 Q2 filed Aug. 11, 2015
- Charlemagne Capital 2015 Q1 filed May 12, 2015
- Charlemagne Capital 2014 Q4 filed Feb. 6, 2015
- Charlemagne Capital 2014 Q3 filed Nov. 5, 2014
- Charlemagne Capital 2014 Q2 restated filed Aug. 14, 2014
- Charlemagne Capital 2014 Q2 filed Aug. 11, 2014
- Charlemagne Capital 2014 Q1 filed May 13, 2014
- Charlemagne Capital 2013 Q4 filed Feb. 11, 2014
- Charlemagne Capital 2013 Q3 filed Nov. 7, 2013